Abbott India Limited
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹488.71 billion
- Book Value:
- Revenue TTM:
- ₹55.24 billion
- Operating Margin TTM:
- Gross Profit TTM:
- ₹22.51 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Abbott India Limited had its IPO on under the ticker symbol ABBOTINDIA.
The company operates in the Healthcare sector and Drug Manufacturers-General industry. Abbott India Limited has a staff strength of 3,700 employees.
Shares of Abbott India Limited opened at ₹23029 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹22746.3 - ₹23250, and closed at ₹22897.25.
This is a -0.38% slip from the previous day's closing price.
A total volume of 18,817 shares were traded at the close of the day’s session.
In the last one week, shares of Abbott India Limited have increased by +2.47%.
Abbott India Limited's Key Ratios
Abbott India Limited has a market cap of ₹488.71 billion, indicating a price to book ratio of 15.9761 and a price to sales ratio of 8.4141.
In the last 12-months Abbott India Limited’s revenue was ₹55.24 billion with a gross profit of ₹22.51 billion and an EBITDA of ₹12.51 billion. The EBITDA ratio measures Abbott India Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Abbott India Limited’s operating margin was 22.18% while its return on assets stood at 16.23% with a return of equity of 31.6%.
In Q2, Abbott India Limited’s quarterly earnings growth was a positive 41.1% while revenue growth was a positive 13.4%.
Abbott India Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹487.39 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Abbott India Limited’s profitability.
Abbott India Limited stock is trading at a EV to sales ratio of 8.0781 and a EV to EBITDA ratio of 32.624. Its price to sales ratio in the trailing 12-months stood at 8.4141.
Abbott India Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0.78% and a payout ratio of 36.99%.
Balance sheet and cash flow metrics
- Total Assets
- ₹45.56 billion
- Total Liabilities
- ₹12.06 billion
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Abbott India Limited ended 2023 with ₹45.56 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹45.56 billion while shareholder equity stood at ₹31.89 billion.
Abbott India Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹12.06 billion in other current liabilities, in common stock, ₹24.29 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹2.40 billion and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Abbott India Limited’s total current assets stands at ₹30.25 billion while long-term investments were ₹0 and short-term investments were ₹17.68 billion. Its net receivables were ₹3.17 billion compared to accounts payable of ₹8.92 billion and inventory worth ₹6.49 billion.
In 2023, Abbott India Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Abbott India Limited paid ₹0.37 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Abbott India Limited stock is currently trading at ₹22897.25 per share. It touched a 52-week high of ₹24724.9492 and a 52-week low of ₹24724.9492. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹23401.96 and 200-day moving average was ₹21864.19 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7498.6% of the company’s stock are held by insiders while 746% are held by institutions.
Frequently Asked Questions About Abbott India Limited
Similar Industry Stocks (Drug Manufacturers-General)
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women’s health, gastroenterology, metabolic, central nervous system, and vaccines, as well as multispecialty products for insomnia, vitamin D, pre-term labor, and pain management; and anti-infectives, cardio-diabetic, hormones, respiratory, hepatic, consumer care, gastro. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.